CompletedPhase 4

Short-term Prednisone to Treat STA Study(SPTSS)

China40 participantsStarted 2013-03

Plain-language summary

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis The investigators hypothesize that less adverse reactions will be observed, comparing with the guidelines recommend. The recurrence rate, adrenal insufficiency, temporary and permanent hypothyroidism aren't significant difference.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-70 years patients with Moderate and severe subacute thyroiditis Exclusion Criteria: * adrenal cortical dysfunction, * use of corticosteroids in nearly three months, * mild subacute thyroiditis, * non-onset STA, * family history of diabetes, * gastric ulcer, * the special medication history, * heart，liver and renal insufficiency, * tumors, * tuberculosis and * poor compliance.

What they're measuring

The Efficiency of experimental group comparing with control group during 14 days

Timeframe: 14 days

Trial details

NCT IDNCT01837433

SponsorXinqiao Hospital of Chongqing

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Subacute Thyroiditis trials